Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,619
in 1 filing, $6K under 10b5-1 plans

Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Prener Anne −$6K Director sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2020-04-13 Nussbaum Ran Director Conversion · Series B-1 Preferred Stock −68,654 0
2020-04-13 Nussbaum Ran Director Conversion · Series C Preferred Stock −163,612 0
2020-04-13 Nussbaum Ran Director Conversion · Series C Preferred Stock −88,460 0
2020-04-13 Nussbaum Ran Director Conversion · Series C Preferred Stock −79,653 0
2020-04-13 Nussbaum Ran Director Conversion · Series C Preferred Stock −36,858 0
2020-04-13 Lazarus Alon Director Conversion +1,382,295 1,382,295
2020-04-13 Lazarus Alon Director Conversion +343,270 1,725,565
2020-04-13 Lazarus Alon Director Conversion +167,537 1,893,102
2020-04-13 Lazarus Alon Director Purchase +120,000 $16.00 $1.9M 2,013,102
2020-04-13 Lazarus Alon Director Conversion · Series A Preferred Stock −1,382,295 0
2020-04-13 Lazarus Alon Director Conversion · Series B-1 Preferred Stock −343,270 0
2020-04-13 Lazarus Alon Director Conversion · Series C Preferred Stock −167,537 0
2020-04-13 Knowles Julius Director Conversion +276,459 414,688
2020-04-13 Knowles Julius Director Conversion +184,305 276,458
2020-04-13 Knowles Julius Director Conversion +205,962 620,650
2020-04-13 Knowles Julius Director Conversion +137,308 413,766
2020-04-13 Knowles Julius Director Conversion +67,015 687,665
2020-04-13 Knowles Julius Director Conversion +44,676 458,442
2020-04-13 Knowles Julius Director Conversion · Series A Preferred Stock −276,459 0
2020-04-13 Knowles Julius Director Conversion · Series A Preferred Stock −184,305 0

Page 33 of 36 · 707 trades